Tazobactam [tazobaktam]
- Terms
-
sodná sůl tazobaktamu
-
Tazobactam Sodium
YTR 830
YTR 830H
YTR-830
A penicillanic acid and sulfone derivative and potent BETA-LACTAMASE inhibitor that enhances the activity of other anti-bacterial agents against beta-lactamase producing bacteria.
- DUI
- D000078142 MeSH Browser
- CUI
- M0127405
- CAS
- 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S,3S,5R)-
- History note
- 2019 (1985)
- Public note
- 2019; TAZOBACTAM was indexed under PENICILLANIC ACIDS 1985-1993; and under PENICILLANIC ACIDS/analogs & derivatives 1994-2018
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 5
- PO
- poisoning
- RE
- radiation effects
- ST
- standards 1
- SD
- supply & distribution
- TU
- therapeutic use 5
- TO
- toxicity
- UR
- urine
ceftolozane, tazobactam drug combination Chemical MeSH Browser